{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:00:12Z","timestamp":1780376412784,"version":"3.54.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20354"],"award-info":[{"award-number":["U21A20354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82250004"],"award-info":[{"award-number":["82250004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81920108010"],"award-info":[{"award-number":["81920108010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81721001"],"award-info":[{"award-number":["81721001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tem.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T16:07:37Z","timestamp":1736179657000},"page":"789-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeting cholesterol-dependent adrenal steroidogenesis for management of primary aldosteronism"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-530X","authenticated-orcid":false,"given":"Hao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3472-9898","authenticated-orcid":false,"given":"Xiaoyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6297-2962","authenticated-orcid":false,"given":"Zhiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2024.12.001_bb0005","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","article-title":"Primary aldosteronism: state-of-the-art review","volume":"35","author":"Vaidya","year":"2022","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.tem.2024.12.001_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0015","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0025","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","article-title":"Clinical management of primary aldosteronism: an update","volume":"81","author":"Rossi","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2024.12.001_bb0035","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tem.2024.12.001_bb0040","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.3390\/ijms24065782","article-title":"Molecular and epigenetic control of aldosterone synthase, CYP11B2 and 11-hydroxylase, CYP11B1","volume":"24","author":"Takeda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.12.001_bb0045","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.2019-00996","article-title":"Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact","volume":"104","author":"Heinrich","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0050","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/a-2221-3302","article-title":"Renal function evolution and hypoaldosteronism risk after unilateral adrenalectomy for primary aldosteronism","volume":"56","author":"Queiroz","year":"2024","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2024.12.001_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism - a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molmed.2020.05.005","article-title":"Genetic and genomic mechanisms of primary aldosteronism","volume":"26","author":"Fernandes-Rosa","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0075","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0080","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2024.12.001_bb0085","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2024.12.001_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H mutations are associated with different forms of primary aldosteronism","volume":"13","author":"Daniil","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2024.12.001_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrneph.2018.17","article-title":"Hypertension: CLCN2 chloride channel mutations in primary aldosteronism","volume":"14","author":"Allison","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.tem.2024.12.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106062","article-title":"Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA)","volume":"218","author":"Motomura","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2024.12.001_bb0105","first-page":"567","article-title":"Adrenal gland: aldosterone-producing mutations in normal adrenal glands","volume":"11","author":"Geach","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2015.07.006","article-title":"Pharmacological treatment of aldosterone excess","volume":"154","author":"Deinum","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tem.2024.12.001_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.934326","article-title":"Primary aldosteronism: pathophysiological mechanisms of cell death and proliferation","volume":"13","author":"Tetti","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2024.12.001_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/a-2172-7228","article-title":"Salt and aldosterone - reciprocal and combined effects in preclinical models and humans","volume":"56","author":"Chen","year":"2024","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2024.12.001_bb0125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.123.19569","article-title":"Tangram of sodium and fluid balance","volume":"81","author":"Bagordo","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0130","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jamacardio.2018.3676","article-title":"Association of age with blood pressure across the lifespan in isolated yanomami and yekwana villages","volume":"3","author":"Mueller","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.tem.2024.12.001_bb0135","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2024.12.001_bb0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/HYPERTENSIONAHA.116.07615","article-title":"Dietary salt intake is a determinant of cardiac changes after treatment of primary aldosteronism: a prospective study","volume":"68","author":"Catena","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0145","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.123.20953","article-title":"Hypertension in primary aldosteronism is initiated by salt-induced increases in vascular resistance with reductions in cardiac output","volume":"80","author":"Kurtz","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0150","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/ATVBAHA.111.242719","article-title":"Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in dahl salt-sensitive rats","volume":"32","author":"Morizane","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2024.12.001_bb0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/ajh\/hpaa208","article-title":"Paradoxical increase of 24-hour urinary aldosterone levels in obese patients with resistant hypertension on a high salt diet","volume":"34","author":"Dudenbostel","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.tem.2024.12.001_bb0160","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1210\/clinem\/dgad512","article-title":"Elevated blood pressure and aldosterone dysregulation in young black women versus white women on controlled sodium diets","volume":"109","author":"Yuan","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0165","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2007-1088","article-title":"Body mass index predicts aldosterone production in normotensive adults on a high-salt diet","volume":"92","author":"Bentley-Lewis","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/hr.2015.42","article-title":"Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life","volume":"38","author":"Demura","year":"2015","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.tem.2024.12.001_bb0175","article-title":"Epigenetic and transcriptional regulation of the human angiotensinogen gene by high salt","author":"Perla","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.tem.2024.12.001_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008281","article-title":"Epigenetic regulation of aldosterone synthase gene by sodium and angiotensin II","volume":"7","author":"Takeda","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.tem.2024.12.001_bb0185","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/HJH.0000000000002742","article-title":"Effect of potassium on DNA methylation of aldosterone synthase gene","volume":"39","author":"Takeda","year":"2021","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2024.12.001_bb0190","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.3390\/ijms22094587","article-title":"DNA methylation of the angiotensinogen gene, AGT, and the aldosterone synthase gene, CYP11B2 in cardiovascular diseases","volume":"22","author":"Takeda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.12.001_bb0195","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13148-022-01347-y","article-title":"Whole blood methylome-derived features to discriminate endocrine hypertension","volume":"14","author":"Armignacco","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.tem.2024.12.001_bb0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-15-0148","article-title":"Integration of transcriptome and methylome analysis of aldosterone-producing adenomas","volume":"173","author":"Murakami","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0205","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/HYPERTENSIONAHA.116.08313","article-title":"Hypomethylation of CYP11B2 in aldosterone-producing adenoma","volume":"68","author":"Yoshii","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2024.12.001_bb0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1043-2760(01)00538-0","article-title":"Regulation of cholesterol supply for mineralocorticoid biosynthesis","volume":"13","author":"Capponi","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100191","article-title":"The role of lipid second messengers in aldosterone synthesis and secretion","volume":"63","author":"Spaulding","year":"2022","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2024.12.001_bb0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.vh.2023.06.007","article-title":"Regulation of lipid droplets and cholesterol metabolism in adrenal cortical cells","volume":"124","author":"Dalen","year":"2024","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.tem.2024.12.001_bb0235","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/JOE-16-0237","article-title":"Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production","volume":"232","author":"Tsai","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0240","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1388-1981(03)00020-9","article-title":"Regulation of the scavenger receptor BI and the LDL receptor by activators of aldosterone production, angiotensin II and PMA, in the human NCI-H295R adrenocortical cell line","volume":"1631","author":"Pilon","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2024.12.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae032","article-title":"Cholesterol availability and adrenal steroidogenesis","volume":"165","author":"Gomez-Sanchez","year":"2024","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2024.12.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106116","article-title":"Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism","volume":"221","author":"Harashima","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2024.12.001_bb0255","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.3390\/cancers13215582","article-title":"Transcriptomics, epigenetics, and metabolomics of primary aldosteronism","volume":"13","author":"Spyroglou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2024.12.001_bb0260","doi-asserted-by":"crossref","first-page":"C1107","DOI":"10.1152\/ajpcell.00083.2020","article-title":"Regulation of Na\/K-ATPase expression by cholesterol: isoform specificity and the molecular mechanism","volume":"319","author":"Zhang","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tem.2024.12.001_bb0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10863-024-10010-5","article-title":"Analysis of cholesterol-recognition motifs of the plasma membrane Ca(2+)-ATPase","volume":"56","author":"Delgado-Coello","year":"2024","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.tem.2024.12.001_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.701263","article-title":"Non-canonical effects of ACTH: insights into adrenal insufficiency","volume":"12","author":"Hasenmajer","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2024.12.001_bb0275","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1210\/endo.142.10.8412","article-title":"Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I","volume":"142","author":"Cherradi","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2024.12.001_bb0280","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacl.2017.03.018","article-title":"Cholesterol delivery to the adrenal glands estimated by adrenal venous sampling: an in vivo model to determine the contribution of circulating lipoproteins to steroidogenesis in humans","volume":"11","author":"Buitenwerf","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.tem.2024.12.001_bb0285","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4128174","article-title":"Physiological aldosterone concentrations are associated with alterations of lipid metabolism: observations from the general population","volume":"2018","author":"Hannich","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.tem.2024.12.001_bb0290","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12902-022-01135-y","article-title":"The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review","volume":"22","author":"Manosroi","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.tem.2024.12.001_bb0295","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3803\/EnM.2021.1012","article-title":"Lipid profiles in primary aldosteronism compared with essential hypertension: propensity-score matching study","volume":"36","author":"Moon","year":"2021","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"10.1016\/j.tem.2024.12.001_bb0300","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/biomedicines11071934","article-title":"Diagnostic accuracy of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for the subtyping of primary aldosteronism","volume":"11","author":"Araujo-Castro","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.tem.2024.12.001_bb0305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem-57-3-477","article-title":"The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism","volume":"57","author":"Gross","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jch.14607","article-title":"Meta-analysis of blood parameters related to lipid and glucose metabolism between two subtypes of primary aldosteronism","volume":"25","author":"Zhu","year":"2023","journal-title":"J. Clin. Hypertens (Greenwich)"},{"key":"10.1016\/j.tem.2024.12.001_bb0315","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12020-016-0983-9","article-title":"Worsening of lipid metabolism after successful treatment of primary aldosteronism","volume":"54","author":"Adolf","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2024.12.001_bb0320","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.120.16440","article-title":"Altered taste perception for sodium chloride in patients with primary aldosteronism: a prospective cohort study","volume":"77","author":"Adolf","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0325","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.119.13358","article-title":"Impairment of bitter taste sensor transient receptor potential channel M5-mediated aversion aggravates high-salt intake and hypertension","volume":"74","author":"Cui","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0330","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/HYPERTENSIONAHA.120.14871","article-title":"Effects of ramipril on the aldosterone\/renin ratio and the aldosterone\/angiotensin II ratio in patients with primary aldosteronism","volume":"76","author":"Guo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0335","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0340","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0345","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jama.2024.8590","article-title":"New cardiovascular disease risk calculator could eliminate the need for statins for millions","volume":"332","author":"Larkin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2024.12.001_bb0350","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jama.2023.2487","article-title":"Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial","volume":"329","author":"Hong","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2024.12.001_bb0355","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/CIRCULATIONAHA.115.016759","article-title":"Statin use and adrenal aldosterone production in hypertensive and diabetic subjects","volume":"132","author":"Baudrand","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2024.12.001_bb0360","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the us preventive services task force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2024.12.001_bb0365","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/HYPERTENSIONAHA.120.14777","article-title":"Interplay between statins, CAV1 (Caveolin-1), and aldosterone","volume":"76","author":"Haas","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0370","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/meta.2000.7716a","article-title":"Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia","volume":"49","author":"Dobs","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2024.12.001_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112803","article-title":"YM750, an acat inhibitor, acts on adrenocortical cells to inhibit aldosterone secretion due to depolarization","volume":"23","author":"Shimada","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2024.12.001_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1254221","article-title":"Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting","volume":"14","author":"Maumus-Robert","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2024.12.001_bb0385","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3390\/jcm10112504","article-title":"The effect of the PCSK9 inhibitor evolocumab on aldosterone secretion among high cardiovascular risk patients: a pilot study","volume":"10","author":"Izkhakov","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0390","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.CIR.0000043244.13596.20","article-title":"Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation","volume":"107","author":"Horiuchi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2024.12.001_bb0395","first-page":"80","article-title":"Effects of statins on renin-angiotensin system","volume":"8","author":"Kiaie","year":"2021","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.tem.2024.12.001_bb0400","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","article-title":"Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men","volume":"100","author":"Nickenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2024.12.001_bb0405","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jcb.25401","article-title":"Statins modulate cyclooxygenase-2 and microsomal prostaglandin e synthase-1 in human hepatic myofibroblasts","volume":"117","author":"Mouawad","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.tem.2024.12.001_bb0410","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s43018-022-00358-1","article-title":"Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer","volume":"3","author":"Guo","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tem.2024.12.001_bb0415","article-title":"Statins as anti-tumor agents: a paradigm for repurposed drugs","volume":"7","author":"Tripathi","year":"2024","journal-title":"Cancer Rep. (Hoboken)"},{"key":"10.1016\/j.tem.2024.12.001_bb0420","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa2208275","article-title":"Polypill strategy in secondary cardiovascular prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6617905","article-title":"Role of statins in the primary prevention of atherosclerotic cardiovascular disease and mortality in the population with mean cholesterol in the near-optimal to borderline high range: a systematic review and meta-analysis","volume":"2020","author":"Singh","year":"2020","journal-title":"Adv. Prev. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0430","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"Raber","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2024.12.001_bb0435","article-title":"Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride","volume":"12","author":"Graudal","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tem.2024.12.001_bb0440","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.tem.2024.12.001_bb0445","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism","volume":"101","author":"Baudrand","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/joim.13618","article-title":"Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: the salt conntrol trial","volume":"294","author":"Schneider","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0455","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41440-023-01204-2","article-title":"Aldosterone breakthrough from a pharmacological perspective","volume":"46","author":"Alfie","year":"2023","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.tem.2024.12.001_bb0460","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/jch.14645","article-title":"Statin's role on blood pressure levels: meta-analysis based on randomized controlled trials","volume":"25","author":"Liu","year":"2023","journal-title":"J. Clin. Hypertens (Greenwich)"},{"key":"10.1016\/j.tem.2024.12.001_bb0465","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/jcm7110382","article-title":"Plasma aldosterone concentration as a determinant for statin use among middle-aged hypertensive patients for atherosclerotic cardiovascular disease","volume":"7","author":"Lin","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tem.2024.12.001_bb0470","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","article-title":"Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2024.12.001_bb0475","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1210\/clinem\/dgac394","article-title":"Characterization of aldosterone-producing cell cluster (APCC) at single-cell resolution","volume":"107","author":"Iwahashi","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0480","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.118.11733","article-title":"Proteomic landscape of aldosterone-producing adenoma","volume":"73","author":"Swierczynska","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2024.12.001_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106445","article-title":"Urine steroid metabolomics as a diagnostic tool in primary aldosteronism","volume":"237","author":"Prete","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2024.12.001_bb0490","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2024.12.001_bb0495","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/a-1141-3526","article-title":"Developments in primary aldosteronism subtyping using steroid profiling","volume":"52","author":"Wannachalee","year":"2020","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tem.2024.12.001_bb0500","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.3390\/cancers13153716","article-title":"Primary aldosteronism: metabolic reprogramming and the pathogenesis of aldosterone-producing adenomas","volume":"13","author":"Gong","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2024.12.001_bb0505","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tem.2024.12.001_bb0510","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2004.08.002","article-title":"Non-genomic effects of aldosterone: new actions and questions","volume":"15","author":"Chun","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.12.001_bb0515","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/bs.vh.2018.10.002","article-title":"Inhibitors of aldosterone synthase","volume":"109","author":"Weldon","year":"2019","journal-title":"Vitam. Horm."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024003230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024003230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:34:12Z","timestamp":1757349252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276024003230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":103,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1043276024003230"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2024.12.001","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cholesterol-dependent adrenal steroidogenesis for management of primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}